Simmonds SJ, Cuijpers I, Heymans S, Jones EAV. Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding. Cells. 2020;9(1):242. https://doi.org/10.3390/cells9010242.
CAS Article PubMed Central Google Scholar
Maeder MT, Rickli H. Heart failure with preserved left ventricular ejection fraction. Praxis (Bern 1994). 2013;102(21):1299–307. https://doi.org/10.1024/1661-8157/a001439.
Ma C, Luo H, Fan L, Liu X, Gao C. Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis. Braz J Med Biol Res. 2020;53(7):e9646. https://doi.org/10.1590/1414-431X20209646.
CAS Article PubMed PubMed Central Google Scholar
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.
CAS PubMed Article Google Scholar
Nunes RB, Alves JP, Kessler LP, Dal Lago P. Aerobic exercise improves the inflammatory profile correlated with cardiac remodeling and function in chronic heart failure rats. Clinics (Sao Paulo). 2013;68(6):876–82.
Pandey A, Darden D, Berry JD. Low fitness in midlife: a novel therapeutic target for heart failure with preserved ejection fraction prevention. Prog Cardiovasc Dis. 2015;58(1):87–93.
Leggio M, Fusco A, Loreti C, et al. Effects of exercise training in heart failure with preserved ejection fraction: an updated systematic literature review. Heart Fail Rev. 2020;25(5):703–11.
CAS PubMed Article Google Scholar
Bernardo BC, Ooi JYY, Weeks KL, Patterson NL, McMullen JR. Understanding key mechanisms of exercise-induced cardiac protection to mitigate disease: current knowledge and emerging concepts. Physiol Rev. 2018;98(1):419–75.
CAS PubMed Article Google Scholar
Jiang HK, Miao Y, Wang YH, et al. Aerobic interval training protects against myocardial infarction-induced oxidative injury by enhancing antioxidase system and mitochondrial biosynthesis. Clin Exp Pharmacol Physiol. 2014;41(3):192–201.
Stølen T, Shi M, Wohlwend M, et al. Effect of exercise training on cardiac metabolism in rats with heart failure. Scand Cardiovasc J. 2020;54(2):84–91.
Garza MA, Wason EA, Zhang JQ. Cardiac remodeling and physical training post myocardial infarction. World J Cardiol. 2015;7(2):52–64.
PubMed PubMed Central Article Google Scholar
Xing W, Li Y, Zhang H, et al. Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2013;305(8):H1111–9. https://doi.org/10.1152/ajpheart.00290.2013.
CAS Article PubMed PubMed Central Google Scholar
Kitzman DW, Brubaker P, Morgan T, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2016;315(1):36–46.
CAS PubMed PubMed Central Article Google Scholar
Eaton CB, Pettinger M, Rossouw J, et al. Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ Heart Fail. 2016;9(10):e002883. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002883.
Article PubMed PubMed Central Google Scholar
Altara R, Giordano M, Nordén ES, et al. Targeting obesity and diabetes to treat heart failure with preserved ejection fraction. Front Endocrinol. 2017;8:160. https://doi.org/10.3389/fendo.2017.00160.
Warbrick I, Rabkin SW. Hypoxia-inducible factor 1-alpha (HIF-1alpha) as a factor mediating the relationship between obesity and heart failure with preserved ejection fraction. Obes Rev. 2019;20(5):701–12.
CAS PubMed Article Google Scholar
Kessler EL, Oerlemans MIFJ, van den Hoogen P, Yap C, Sluijter JPG, de Jager SCA. Immunomodulation in heart failure with preserved ejection fraction: current state and future perspectives. J Cardiovasc Transl Res. 2021;14(1):63–74.
Savji N, Meijers WC, Bartz TM, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC: Heart Fail. 2018;6(8):701–9.
Hicklin HE, Gilbert ON, Ye F, Brooks JE, Upadhya B. Hypertension as a road to treatment of heart failure with preserved ejection fraction. Curr Hypertens Rep. 2020;22(10):82. https://doi.org/10.1007/s11906-020-01093-7.
Zhou G, Chen J, Wu C, et al. Deciphering the protein, modular connections and precision medicine for heart failure with preserved ejection fraction and hypertension based on TMT quantitative proteomics and molecular docking. Front Physiol. 2021;12:607089. https://doi.org/10.3389/fphys.2021.607089.
Article PubMed PubMed Central Google Scholar
Adamczak DM, Oduah MT, Kiebalo T, et al. Heart failure with preserved ejection fraction—a concise review. Curr Cardiol Rep. 2020;22(9):82. https://doi.org/10.1007/s11886-020-01349-3.
Article PubMed PubMed Central Google Scholar
Lin Y, Fu S, Yao Y, Li Y, Zhao Y, Luo L. Heart failure with preserved ejection fraction based on aging and comorbidities. J Transl Med. 2021;19(1):291. https://doi.org/10.1186/s12967-021-02935-x.
Article PubMed PubMed Central Google Scholar
Bustamante M, Garate-Carrillo A, Ito BR, et al. Unmasking of oestrogen-dependent changes in left ventricular structure and function in aged female rats: a potential model for pre-heart failure with preserved ejection fraction. J Physiol. 2019;597(7):1805–17.
CAS PubMed PubMed Central Article Google Scholar
Sweeney M, Corden B, Cook SA. Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? EMBO Mol Med. 2020;12(10):e10865. https://doi.org/10.15252/emmm.201910865.
CAS Article PubMed PubMed Central Google Scholar
Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2021;18(6):400–23.
PubMed PubMed Central Article Google Scholar
Jannapureddy S, Sharma M, Yepuri G, Schmidt AM, Ramasamy R. Aldose reductase: an emerging target for development of interventions for diabetic cardiovascular complications. Front Endocrinol. 2021;12:636267. https://doi.org/10.3389/fendo.2021.636267.
Mgbemena O, Zhang Y, Velarde G. Role of diabetes mellitus in heart failure with preserved ejection fraction: a review article. Cureus. 2021;13(11):e19398. https://doi.org/10.7759/cureus.19398.
Article PubMed PubMed Central Google Scholar
Gandhi PU, Gaggin HK, Redfield MM, et al. Insulin-like growth factor-binding protein-7 as a biomarker of diastolic dysfunction and functional capacity in heart failure with preserved ejection fraction: results from the RELAX trial. JACC: Heart Fail. 2016;4(11):860–9.
Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tschöpe C. Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction—a specific HFpEF phenotype. Front Cardiovasc Med. 2021;8:720690. https://doi.org/10.3389/fcvm.2021.720690.
CAS Article PubMed PubMed Central Google Scholar
Pieske B, Tschöpe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297–317.
Harada T, Kagami K, Kato T, Ishii H, Obokata M. Exercise stress echocardiography in the diagnostic evaluation of heart failure with preserved ejection fraction. J Cardiovasc Dev Dis. 2022;9(3):87. https://doi.org/10.3390/jcdd9030087.
Article PubMed PubMed Central Google Scholar
Donal E, Lund LH, Oger E, et al. Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study. Eur Heart J Cardiovasc Imaging. 2016;17(1):106–13.
Belyavskiy E, Morris DA, Url-Michitsch M, et al. Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study. ESC Heart Fail. 2019;6(1):146–53.
Ezzatvar Y, Izquierdo M, Núñez J, Calatayud J, Ramírez-Vélez R, García-Hermoso A. Cardiorespiratory fitness measured with cardiopulmonary exercise testing and mortality in patients with cardiovascular disease: a systematic review and meta-analysis. J Sport Health Sci. 2021;10(6):609–19.
PubMed PubMed Central Article Google Scholar
Finet JE, Van Iterson EH, Wilson Tang WH. Invasive hemodynamic and metabolic evaluation of HFpEF. Curr Treat Options Cardiovasc Med. 2021;23(5):32. https://doi.org/10.1007/s11936-021-00904-7.
Article PubMed PubMed Central Google Scholar
Malhotra R, Bakken K, D’Elia E, Lewis GD. Cardiopulmonary exercise testing in heart failure. JACC: Heart Fail. 2016;4(8):607–16.
Kaye DM, Wolsk E, Nanayakkara S, et al. Comprehensive physiological modeling provides novel insights into heart failure with preserved ejection fraction physiology. J Am Heart Assoc. 2021;10(19):e021584. https://doi.org/10.1161/JAHA.121.021584.
Article PubMed PubMed Central Google Scholar
Sorimachi H, Burkhoff D, Verbrugge FH, et al. Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(10):1648–58.
留言 (0)